This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Prohibits the use of federal funds for gender transition procedures and blocks certain federal tax credits for health plans that cover those procedures. It also directs the multi-State plan program to ensure no multi-State qualified health plan provides benefits paid with federal funds for these procedures, while allowing separate, non‑subsidized coverage to be sold or offered for such care. The bill adds a new chapter to Title 1 of the U.S. Code to bar federally funded gender transition procedures (the text of that new chapter is not included in the materials provided). It amends the tax code to deny premium tax credits and the small employer health insurance credit for plans that include coverage of "gender transition procedures" as defined in the new Title 1 chapter (with a specified exclusion), and sets timing rules for when the tax and plan changes take effect.
The bill prioritizes reducing federal funding and clarifying rules against taxpayer-subsidized gender transition procedures—saving federal outlays and creating administrative certainty—at the cost of restricting access to care for transgender people and imposing financial and administrative burdens on patients, employers, insurers, and health systems.
Taxpayers and the federal budget will not subsidize gender transition procedures through federal programs, reducing federal spending exposure for those benefits.
Provides statutory clarity to federal agencies, programs, and multi-State plans that federal funds may not be used for gender transition procedures, reducing ambiguity for administrators and program managers.
Limits use of premium tax credits and small-employer tax credits to plans that exclude gender transition procedures, which could lower federal subsidy outlays tied to those specific benefits.
People who rely on federal health programs (Medicaid beneficiaries, veterans, and federal employees) could lose access to gender-affirming care when those programs are barred from funding transition-related procedures.
Patients who depend on federal coverage may face higher out-of-pocket costs for transition-related care, increasing financial burden on low-income individuals and people with chronic conditions.
Marketplace enrollees who receive premium tax credits could see fewer plan choices or higher costs if insurers drop gender transition coverage to retain subsidies, reducing affordable options for low-income consumers.
Introduced March 12, 2025 by Roger Wayne Marshall · Last progress March 12, 2025